Loading clinical trials...
Loading clinical trials...
A Study to Evaluate the Efficacy of the Valsartan/Simvastatin Combinations 160/20mg up Titrated to 320/20mg Versus 160/40mg up Titrated to 320/40mg in Patients With Both Essential Hypertension and Hypercholesterolemia
Conditions
Interventions
simvastatin
valsartan
Locations
2
Germany
Investigative Centers, Germany
Novartis Pharmaceuticals
Basel, Switzerland
Start Date
November 1, 2005
Primary Completion Date
September 1, 2006
Completion Date
September 1, 2006
Last Updated
August 19, 2014
NCT07058077
NCT06823947
NCT06555120
NCT06287177
NCT00353782
NCT06556745
Lead Sponsor
Novartis
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions